Clinical Trial Update: Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors

View source ↗

Summary

A completed non-interventional study assessing whether patients treated with HMG-CoA reductase inhibitors reach cholesterol target values.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Statins

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolaemia | Status: COMPLETED